NCT00200473View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

March 31, 2003

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Trial Locations (1)

26505

Mylan Pharmaceuticals Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY